Salma - OmicsDI

Show results for

Unknown (99)
Transcriptomics (10)
Models (3)
Metabolomics (2)
Genomics (2)
Proteomics (1)

Organisms

Arabidopsis thaliana (7)
Homo sapiens (4)
Mus musculus (2)
Oryza sativa (1)

Repository

biostudies-arrayexpress (10)
BioModels (3)
MetaboLights (2)
ENA (2)
pride (1)

Tissue

Rosette (1)

Disease

Cancer (3)
Acute Myeloid Leukemia (1)

Technology Type

Mass spectrometry (2)
Affinity purification coupled with mass spectrometry proteomics (1)
Mass Spectrometry (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS – negative - reverse phase (1)

Publication Date

2013 (4)
2024 (3)
2016 (2)
2014 (2)
2022 (2)
2011 (1)
2010 (1)
2025 (1)

CHEBI ID

CHEBI:144829 (3)
CHEBI:15940 (2)
CHEBI:16335 (2)
CHEBI:16393 (2)
CHEBI:16566 (2)
CHEBI:16708 (2)
CHEBI:16709 (2)
CHEBI:16750 (2)
CHEBI:16811 (2)
CHEBI:17015 (2)
CHEBI:17126 (2)
CHEBI:17154 (2)
CHEBI:17310 (2)
CHEBI:17750 (2)
CHEBI:17964 (2)
CHEBI:18183 (2)
CHEBI:18186 (2)
CHEBI:18237 (2)
CHEBI:22660 (2)
CHEBI:24898 (2)
CHEBI:26271 (2)
CHEBI:26986 (2)
CHEBI:27266 (2)
CHEBI:27570 (2)
CHEBI:28044 (2)
CHEBI:29016 (2)
CHEBI:30769 (2)
CHEBI:49033 (2)
CHEBI:73770 (2)
CHEBI:73907 (2)

Metabolite Name

2-Deoxyribose 5-phosphate (1)
2-Hydroxy-4-methylpentanoate (1)
2-Methylglutaric acid (1)
2-Oxoglutaric acid (1)
3,4-Dihydroxymandelic acidÊ (1)
3-Dehydroshikimic acid (1)
3-Methoxy-4-hydroxymandelate (1)
4-Guanidinobutyric acid (1)
5-Methoxypsoralen (1)
7,8-Dihydrobiopterin (1)
Abscisic acid (1)
Arachidonic acid (1)
Arachidonyl dopamine (1)
Aspartate (1)
Aurapten (1)
Beta-Hydroxymyristic acid (1)
Biotin (1)
Cholic acid (1)
Citramalate (1)
Citric acid (1)
Cortisol (1)
DAG 34:1 (1)
DAG 34:2 (1)
DAG 34:3 (1)
DAG 36:3 (1)
DAG 36:4 (1)
DAG 36:5 (1)
DGDG 34:1 (1)
DGDG 34:2 (1)
DGDG 34:3 (1)

IsPrivate

False (3)

Submitter Keywords

Immuno-oncology (3)

First Public Date

2025 (1)
2017 (1)

Modelling Approach

Ordinary differential equation model (3)

Study type

Transcription profiling by array (9)
Transcription profiling by RT-PCR (1)

Release Date

2025 (29)
2024 (13)
2022 (13)
2023 (11)
2021 (11)
2013 (5)
2020 (5)
2026 (4)
2016 (3)
2014 (3)
2019 (3)
2018 (3)
2009 (2)
2011 (1)
2010 (1)
2015 (1)
2008 (1)

Lab affiliation

Max-Planck-Institut für Molekulare Pflanzenphysiologie Wissenschaftspark Golm Am Mühlenberg 1 14476 Potsdam, Germany (1)

Previous page
1 / 12
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 12
Next page

Sort by:

Relevance

Page size

Al-Tuwairqi2020 - Dynamics of cancer virotherapy - Phase I treatment

This ordinary differential equation model of cancer virotherapy dynamics is described in the publication: Salma M. Al-Tuwairqi, Najwa O. Al-Johani, Eman A. Simbawa, "Modeling dynamics of cancer radiovirotherapy", Journal of Theoretical Biology, Volume 506, 2020, 110405, ISSN 0022-5193, DOI: 10.1016/...

2024-09-02 | BIOMD0000001031 | BioModels

Immuno-oncology

Al-Tuwairqi2020 - Dynamics of cancer radiovirotherapy - Phase II treatment

This ordinary differential equation model of cancer radiovirotherapy dynamics is described in the publication: Salma M. Al-Tuwairqi, Najwa O. Al-Johani, Eman A. Simbawa, "Modeling dynamics of cancer radiovirotherapy", Journal of Theoretical Biology, Volume 506, 2020, 110405, ISSN 0022-5193, DOI: 10....

2024-09-02 | BIOMD0000001032 | BioModels

Immuno-oncology

Gut microbiome

Computational Modeling of the Gut-Brain Axis in Alzheimer's Disease: Uncovering Microbiome-Derived Metabolites as Predictive Biomarkers

PRJEB87395 | ENA

Halophyte rhizosphere microbiome assemblage

Understanding the effects of soil salinity on rhizosphere microbiome assemblage

PRJEB21253 | ENA

Dispersal of Pleistocene Equus (Family Equidae) into South America and calibration of GABI 3 based on evidence from Tarija, Bolivia.

Not available

S-EPMC3603859 | biostudies-literature

Late middle Miocene caviomorph rodents from Tarapoto, Peruvian Amazonia.